Loading clinical trials...

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol | Clinical Trials | Clareo Health

RECRUITINGPhase 4

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

NCT05682131•Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Arsenic TrioxideChildhood ALL

Interventions

Realgar Indigo naturalis formula

Conventional chemotherapy

Locations

China

Locations (1)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China

Key Dates

Start Date

September 27, 2022

Primary Completion Date

September 27, 2027

Completion Date

September 27, 2030

Last Updated

January 12, 2023

Related Studies

COMPLETEDPhase 3

Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities

NCT06179732

MalariaChildhood ALL+1 more

View study

UNKNOWN

The Association of Gut Microbiota With COVID 19 Infection in Children

NCT05303155

Coronavirus InfectionsGut Microbiome+1 more

View study

Contacts

Pei J Fang, Doctoral

CONTACT

13682290830 jpfang2005@163.com

Jian Wang, Master's

CONTACT

18588935208 459283765@qq.com

Sponsors

Lead Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators

First Affiliated Hospital, Sun Yat-Sen University
Third Affiliated Hospital, Sun Yat-Sen University
Zhujiang Hospital
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou First People's Hospital
Huizhou Municipal Central Hospital
First Affiliated Hospital of Shantou University Medical College
Zhongshan People's Hospital, Guangdong, China
Zhongshan Bo Ai Hospital
First Affiliated Hospital of Guangxi Medical University
LiuZhou People's Hospital
Second Xiangya Hospital of Central South University
Hainan People's Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 12, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions